Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Sarcoma 8Rhabdomyosarcoma 8Wilms Tumor 7Malignant mesenchymal tumor 5Kidney Neoplasms 4Rhabdomyosarcoma, Embryonal 3Neuroectodermal Tumors, Primitive, Peripheral 3Rhabdomyosarcoma, Alveolar 2Hydatidiform Mole 2Gestational Trophoblastic Disease 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Ewing 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Lymphoma 1Liposarcoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Choroid Plexus Neoplasms 1Choriocarcinoma 1Brain Neoplasms 1Blast Crisis 1Beckwith-Wiedemann Syndrome 1

Interventions

Methotrexate 2Dactinomycin 2Vincristine 1Vacuum Curettage 1Paclitaxel 1Moxifloxacin 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Gestational Trophoblastic Disease × Dactinomycin × Clear all
NCT02639650 2022-06-03

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

Women's Hospital School Of Medicine Zhejiang University

Phase 3 Unknown
214 enrolled
Gynecologic

Gestational Trophoblastic Disease

NCT01823315 2019-12-24

GTN-01

Huazhong University of Science and Technology

Phase 3 Unknown
300 enrolled
Gynecologic

Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡